It was identified that the RNAi-mediated reduction of Nrf2 expression in lung cancer cells induces the generation of ROS, decreases the level of reduced glutathione, and results in an increase in the A549 cell proliferation inhibition rate. The gene discussed is NFE2L2; the disease is lung carcinoma.